MyFinsight
Home
Blog
About
Marketable securities
$280,109K
(41.63%↑ Y/Y)
Cash and cash
equivalents
$73,835K
(-25.03%↓ Y/Y)
Prepaid expenses and
other current assets
$13,022K
(121.31%↑ Y/Y)
Total current assets
$366,966K
(21.45%↑ Y/Y)
Other long-term
assets
$9,028K
(-18.73%↓ Y/Y)
Right-of-use asset
$5,311K
Property and equipment,
net
$1,173K
(-16.99%↓ Y/Y)
Restricted cash
$884K
(-11.60%↓ Y/Y)
Total assets
$383,362K
(19.24%↑ Y/Y)
Total liabilities and
stockholders' equity
$383,362K
(19.24%↑ Y/Y)
Total stockholders'
equity
$353,664K
(17.05%↑ Y/Y)
Total liabilities
$29,698K
(53.46%↑ Y/Y)
Accumulated deficit
-$456,121K
(-48.31%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$580K
(-233.03%↓ Y/Y)
Additional paid-in capital
$810,359K
(33.01%↑ Y/Y)
Total current
liabilities
$24,620K
(78.79%↑ Y/Y)
Lease liabilities,
noncurrent
$5,078K
(-9.03%↓ Y/Y)
Common stock, 0.0001
par value...
$6K
(20.00%↑ Y/Y)
Accrued expenses and
other current...
$21,782K
(96.52%↑ Y/Y)
Accounts payable
$2,334K
(3.96%↑ Y/Y)
Lease liabilities,
current
$504K
(14.29%↑ Y/Y)
Back
Back
Balance Sheet
Tyra Biosciences, Inc. (TYRA)
Tyra Biosciences, Inc. (TYRA)
source: myfinsight.com